Women Lack Critical Information On Reducing Recurrence Of Breast Cancer
The adulthood of breast cancer survivors consider themselves stronger after having the disease, according to new survey results. However, the data also suggest women’s knowledge about actions they can put forth to lessen the distinct possibility of recurrence is surprisingly low.
The survey, which was commissioned by AstraZeneca and conducted by Harris Interactive, consisted of interviews with 543 women in the United States who had been diagnosed with breast cancer. The unbounded majority (92 percent) of these women reported a positive metamorphose in their lifestyles since being diagnosed with the disease and scarcely two-thirds (63 percent) said they are hopeful and optimistic about the future. Virtually nine in 10 (87 percent) said that having breast cancer made them a stronger person and about four in five (83 percent) said they were better able to silence their lives in perspective. Owing to the significant focus on at daybreak detection and recent medical and orderly advances, women are surviving core cancer, remaining disease-free and living longer and healthier lives.
The survey also showed that breast cancer survivors are more likely to classify a great stock with other women who have had the disease (66 percent) than with people of the same ethnic/racial background (41 percent) or religious beliefs (40 percent). The survivorship community continues to flourish with more than 2.3 million bosom cancer survivors in the U.S. today, making this the largest group of cancer survivors.
Interestingly, the same view results also advance that there may be a “disconnect” with report regarding the chances of breast cancer returning. While the majority (78 percent) of women who organize had heart cancer are anxious adjacent to recurrence, 30 percent don’t swear by and 23 percent aren’t sure there is anything they can do to lessen the likelihood of a breast cancer recurrence and only respecting half (55 percent) experience oral to their doctor about recurrence. The examination suggests that more action and lore is needed about the many ways, such as healthier eating, reducing stress and taking hormonal therapy, women can help reduce the chance of recurrence.
“For most women, a diagnosis of tit cancer has a significant impact on their lifestyle and the way they monitor their salubrity. We want to substructure all women who play a joke on had breast cancer in getting the best information available to help them persist murrain-unrestrictedly for as long as possible,” said Jean A. Sachs, MSS, MLSP, executive director of Living Beyond Breast Cancer, a nonprofit grouping based excluded of Philadelphia. “We strongly encourage women who have had teat cancer and their loved ones to speak with their health pains professionals to obtain the facts.”
According to the survey, more knocker cancer survivors (72 percent) said they relied heavily on their doctors or health professionals in their path to recovery than said they relied on either friends (67 percent) or spouse (52 percent). The majority of respondents, 89 percent, said that they are rather involved/not embroiled with in a breast cancer survivor community, and as a consequence capacity paucity the support and access to timely information that they want.
The the greater part (87 percent) of breast cancer survivors surveyed said having the disease made them a stronger man, and 63 percent of all respondents are hopeful and optimistic about the tomorrow’s.
—————————-
Article adapted by Medical Statement Today from autochthonous press release.
—————————-
For more information about breast cancer and recurrence, visit http://www.getbcfacts.com/.
SURVEY METHODOLOGY
This examination was conducted online within the Merged States by Harris Interactive on behalf of AstraZeneca between April 17 and 30, 2007 among 555 U.S. women ages 18 and older who have been diagnosed with breast cancer. All figures presented here end in the responses of women who are now spontaneous from breast cancer or currently should prefer to Broadway 0 to IIIA breast cancer (excluding those with Stage IIIB and Exhibit IV heart cancer). Figures for age, race/ethnicity, upbringing, region, and household income were weighted where necessary to bring them into array with their genuine proportions in the natives. Propensity score weighting was also used to rectify for respondents’ propensity to be online.
With a true odds sampler of 555, one could contemplate with a ninety-five percent probability that the overall results would have a sampling error of +/- 6.5 interest points. Sampling error because of data based on sub-samples would be higher and would deviate. However, that does not rent other sources of error into account. This online survey is not based on a probability sample and ergo no putative sampling error can be calculated.
PREVALENT CHEST CANCER
Breast cancer is the most frequently diagnosed cancer in women and is the second best provoke of cancer deaths in women, exceeded only by lung cancer. It is estimated that 40,460 women hand down die of the disease in 2007.2 Mammography screening, which is recommended annually for women 40 years of age and older, frequently detects early signs of breast cancer and, thus, improves survival chances. After increasing for all about two decades, female soul cancer occurrence rates leveled off from 2001 to 2003.2 Mortality rates in women have steadily declined since 1990, decreasing by 3.3 percent per year in women younger than 50 and 2.0 percent per year in those 50 years and older.2
ABOUT HARRIS INTERACTIVE
Harris Interactive is the 12th largest and fastest-growing market research firm in the world. The company provides innovative inspect, insights and tactical communication to aide its clients urge more cool decisions which manage to measurable and enduring improvements in performance. Harris Interactive is extremely known for The Harris Poll, equal of the longest running, independent way of thinking polls and for pioneering online market research methods. The company has built what it believes to be the world’s largest panel of survey respondents, the Harris Poll Online. Harris Interactive serves clients worldwide through its United States, Europe and Asia offices, its unqualifiedly-owned subsidiaries Novatris in France and MediaTransfer AG in Germany, and finished with a extensive network of independent furnish research firms. More advice about Harris Interactive may be obtained at www.harrisinteractive.com. To become a associate of the Harris Ballot Online and be invited to participate in online surveys, inform of at www.harrispollonline.com.
ALL ROUND ASTRAZENECA
AstraZeneca is a major international healthcare responsibility engaged in the research, situation, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is individual of the world’s supreme pharmaceutical companies with healthcare sales of $26.47 billion and leading positions in sales of gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index.
In the United States, AstraZeneca is a $12.44 billion healthcare business with more than 12,000 employees. For about three decades, AstraZeneca has offered drug assistance programs side by side with its medicines, and down the before five years, has provided terminated $3 billion in savings to more than 1 million patients throughout the US and Puerto Rico. AstraZeneca has been named one of the “100 With greatest satisfaction Companies inasmuch as Working Mothers” by Working Nurse periodical and is the only large pharmaceutical corporation named to MONEY magazine’s 2007 list of “100 Most adroitly Companies to Composition For.” In 2006, for the fifth consecutive year, Body of laws ammunition named AstraZeneca a “Top Employer” on its ranking of the world’s most respected biopharmaceutical employers.
Looking for more communication about AstraZeneca, please stopover: http://www.astrazeneca-us.com/
Doubeni, C. A., Field, T. S., Ulcickas, Y. M., Rolnick, S. J., Quessenberry, C. P., Fouayzi, H., et al. (2006). Patterns and predictors of mammography utilization among breast cancer survivors. Cancer, 106(11), 2482-2488, (June 1). 2 American Cancer Society, “Cancer Facts & Figures,” 2007
Provenience: Julian Teixeira
Edelman Celebrated Relations